Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-20

FDA Approved: TYMLOS — Supplemental Application (Radius Health, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TYMLOS (abaloparatide) by Radius Health, Inc. This action reflects an approved supplemental submission for the p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tymlos (abaloparatide)

Snippet

SUPPL AP for TYMLOS (ABALOPARATIDE)